The table below shows Black Diamond Therapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$70.00M
$0.00
-
-
-
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$33.56M
$51.31M
$59.35M
$64.44M
$96.83M
$48.21M
SG&A
$16.57M
BDTX annual revenue (10-K history)
Black Diamond Therapeutics, Inc. reported annual revenue of $70.00M for fiscal year 2025. Figures come from the company's audited annual reports as filed with the SEC.